ANG Lifesciences India Limited (BOM:540694)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Pharmaceuticals	899.10M	1.31B	2.07B	3.49B	1.54B
Pharmaceuticals Growth	-31.56%	-36.54%	-40.63%	125.85%	21.72%
Printing and Packagings	67.63M	183.02M	242.05M	218.97M	-
Printing and Packagings Growth	-63.05%	-24.39%	10.54%	-	-
Inter Segment Revenue	-38.27M	-35.61M	-113.19M	-162.65M	-
Total	928.47M	1.46B	2.20B	3.54B	1.54B
Total Growth	-36.45%	-33.55%	-37.94%	129.50%	21.72%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Outside India	50.53M	43.37M	34.11M	-	107.96M
Outside India Growth	16.50%	27.18%	-	-	584.22%
India	848.57M	1.27B	2.04B	-	1.38B
India Growth	-33.20%	-37.61%	-	-	11.84%
Unallocated	-	-	-	-	51.36M
Unallocated Growth	-	-	-	-	249.96%
Total	899.10M	1.31B	2.07B	-	1.54B
Total Growth	-31.56%	-36.54%	-	-	21.72%

Source: S&P Global Market Intelligence.